Home
Conditions
RNA Virus Infections

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,816 public trials 832 recruiting studies

Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)

NCT02231632

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
Locations: Institute of Medical Biology -Chinese Academy of Medical Sciences Kunming, Yunnan, China 650118 Kunming, Yunnan, China

View Trial Details

Completed

Systematic Offer of Nurse-Driven Screening for COVID-19 in Emergency Departments in the Paris Metropolitan Area, DEPIST-COVID

NCT04756609

Conditions: Coronaviridae Infections, Coronavirus Infections, Infections, +8 more
Locations: URC-EST, Hôpital saint-Antoine Paris, France

View Trial Details

Completed

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older

NCT04789577

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: GSK Investigational Site Stockbridge, Georgia, United States

GSK Investigational Site Meridian, Idaho, United States

GSK Investigational Site Cary, North Carolina, United States

GSK Investigational Site Wilmington, North Carolina, United States

View Trial Details

Completed

The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines

NCT01949857

Conditions: Digestive System Diseases, Enterovirus Infections, Hepatitis, +7 more
Locations: Institute of Medical Biology -Chinese Academy of Medical Sciences Kunming, Yunnan, China

View Trial Details

Completed

Pharmacokinetics and Bioequivalence of XC8 10 mg and 40 mg Tablets in Fasted Volunteers

NCT05558462

Conditions: Infections, Influenza, Influenza, Human, +6 more
Locations: I.M. Sechenov First Moscow State Medical University Moscow, Russia

View Trial Details

Completed

Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease

NCT04988282

Conditions: COVID-19, COVID-19 Pneumonia, Coronaviridae Infections, +13 more
Locations: Ufuk University Medicine Faculty Ankara, Turkey (Türkiye)

View Trial Details

Completed

Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)

NCT04993365

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations: Yangchun Center for Disease Control and Prevention Yangchun, Guangdong, China

Zhanjiang Center for Disease Control and Prevention Zhanjiang, Guangdong, China

View Trial Details

Completed

Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects

NCT00071760

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Jacksonville, Florida, United States

GSK Investigational Site Durham, North Carolina, United States

GSK Investigational Site Buenos Aires, Argentina

GSK Investigational Site Mexico City, Mexico

View all 15 locations

View Trial Details

Completed

Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection

NCT04695379

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, COVID-19, +22 more
Locations: CHU d'Angers Angers, France

CHU de Bordeaux Bordeaux, France

Hospices Civils de Lyon Bron, France

APHP - Hopital Raymond Poincarré Garches, France

View Trial Details

Completed

Efficacy and Safety of Vaccination Against COVID-19 in Neuromuscular Patients

NCT05311904

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations: CHU de Bordeaux Bordeaux, France

View Trial Details

RNA Virus Infections

RNA Virus Infections trial results

Related conditions